The FDA gives Fast Track Priority to uniQure’s Hemophilia B Gene Therapy
UniQure has received Breakthrough Therapy Designation from the FDA, granting fast track to its gene therapy…
January 30, 2017 - 2 minutes
uniQure
UPDATE: The 5 Hottest European Biotechs in 2017 according to JP Morgan
The world's biggest biotech investor conference, hosted by JP Morgan, is now underway in San…
January 11, 2017 - 3 minutes
After a Rough Year, uniQure CMO discusses a Comeback
Last year was a bad year for biotech as an industry, but it was particularly…
January 9, 2017 - 4 minutes
UPDATE: UniQure keeps afloat with a New CEO and More Clinical Data
UniQure's gene therapy for Hemophilia B is performing well in clinical trials, but the company faces…
December 20, 2016 - 3 minutes
UniQure takes an axe to its Pipeline and Workforce in new R&D Strategy
UniQure just announced a new R&D plan designed to save up to €27M over the…
November 17, 2016 - 2 minutes
Cell Therapies: Is Commercialization holding back a Breakthrough?
How far away is biotech from a breakthrough with cell and gene therapy? While these…
November 16, 2016 - 4 minutes
Roche hits a Speed Bump on the way to a Hemophilia Cure
The Swiss pharma is gearing up for a battle with Novo Nordisk in Hemophilia, but…
November 4, 2016 - 4 minutes
Gene Therapy for severe Hemophilia has new Phase I/II Results
uniQure has new data from the Phase I/II trial of its gene therapy for Hemophilia…
July 29, 2016 - 3 minutes
How to build a Successful Biotech company in Europe with Joern Aldag
Joern Aldag is one of the impressive Biotech leaders in Europe. Hearing him at our…
July 11, 2016 - 6 minutes
This Dutch Gene Therapy is on the shelf and seems to Work. But nobody is buying…
uniQure's Glybera was approved in Europe in 2012, making it the first gene therapy on…
May 6, 2016 - 3 minutes
7 Trendy European Biotechs Listed on the NASDAQ in 2016
Here are 7 European Biotechs listed on the NASDAQ we thought were worth mentioning in more…
February 23, 2016 - 6 minutes
2011-2015: What a Fantastic 5 Years for European Biotech
The crisis of 2008 hit the Biotech sector hard, and it wasn't clear how the…
January 26, 2016 - 5 minutes
